Chimerix Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 81

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 20

  • Investments
  • 1

Chimerix General Information

Description

Developer of orally available antiviral therapeutics designed to treat viral diseases. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, as well as royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2505 Meridian Parkway
  • Suite 100
  • Durham, NC 27713
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Vertical(s)
Former Stock Listing
CMRX
Corporate Office
  • 2505 Meridian Parkway
  • Suite 100
  • Durham, NC 27713
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chimerix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Chimerix‘s full profile, request access.

Request a free trial

Chimerix Patents

Chimerix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026231725-A2 Combination therapies for treatment of central nervous system cancers Pending 28-Apr-2025
WO-2025250553-A1 Solid state forms of imipridone derivative Pending 28-May-2024
AU-2023320122-A1 Pharmaceutical compositions and uses thereof for the treatment of glioma Pending 05-Aug-2022
AU-2023320122-A2 Pharmaceutical compositions and uses thereof for the treatment of glioma Pending 05-Aug-2022
EP-4565237-A1 Pharmaceutical compositions and uses thereof for the treatment of glioma Pending 05-Aug-2022 C07D471/14
To view Chimerix’s complete patent history, request access »

Chimerix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chimerix Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Chimerix‘s full profile, request access.

Request a free trial

Chimerix Acquisitions (1)

Chimerix’s most recent deal was a Merger/Acquisition with Oncoceutics for . The deal was made on 07-Jan-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Oncoceutics 07-Jan-2021 Merger/Acquisition Drug Discovery
To view Chimerix’s complete acquisitions history, request access »

Chimerix FAQs

  • When was Chimerix founded?

    Chimerix was founded in 2000.

  • Where is Chimerix headquartered?

    Chimerix is headquartered in Durham, NC.

  • What is the size of Chimerix?

    Chimerix has 81 total employees.

  • What industry is Chimerix in?

    Chimerix’s primary industry is Drug Discovery.

  • Is Chimerix a private or public company?

    Chimerix is a Private company.

  • What is the current valuation of Chimerix?

    The current valuation of Chimerix is .

  • What is Chimerix’s current revenue?

    The current revenue for Chimerix is .

  • How much funding has Chimerix raised over time?

    Chimerix has raised $378M.

  • Who are Chimerix’s investors?

    Aisling Capital, Alta Partners, Asset Management Ventures, Canaan Partners, and Frazier Healthcare Partners are 5 of 11 investors who have invested in Chimerix.

  • When was Chimerix acquired?

    Chimerix was acquired on 21-Apr-2025.

  • Who acquired Chimerix?

    Chimerix was acquired by Jazz Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process